Enhancing MRI Analysis with Prostate.Carcinoma.ai
fully integrated in mint Lesion™
Efficiency and precision for your radiology
mint Lesion™ significantly improves MRI analysis by integrating Prostate.Carcinoma.ai, the intelligent AI power up for PACS and diagnostic DICOM viewers, developed by FUSE-AI. The Prostate.Carcinoma.ai power up is only one click away – upgrade your mint Lesion™ software now!
Prostate.Carcinoma.ai enhances healthcare professionals’ efficiency and empowers their workflow:
Freeing radiologist from repetitive tasks and long throughput times
Reducing the burden of time-consuming and mentally exhausting work
Transforming the diagnostic routine into a smooth, smart and stable productive experience
The Prostate.Carcinoma.ai power up is only one click away – upgrade your mint Lesion™ software now!
Your Benefits
Increased time efficiency
The use of Prostate.Carcinoma.ai helps to mitigate the shortage of skilled medical professionals by automating tedious steps involved in creating manual segmentations, thereby freeing up valuable resources.
More accurate prostate volumetry
More accurate and consistent prostate segmentations in MRI provide more precise prostate volume and PSA density calculations.
Less manual work
Automating manual processes to reduce radiologists' workload can enhance their job satisfaction.
Easy set-up: plug-in solution
The PACS or DICOM Viewer plug-in can be seamlessly integrated into the hospital’s IT system, eliminating the need for additional software installations in everyday clinical practice.
Book your live demo
Fast focus to regions of interests (ROI)
Prostate.Carcinoma.ai automatically segments the prostate, its zones, and conspicuous lesions on all T2w images. A clinical study has shown that this analysis time is reduced by approximately 30%.
Facilitated volumetry
Achieving more accurate calculations of prostate volume and PSA density may contribute to improving urologists' TRUS-guided biopsies with better treatment options.
Manual adaption is possible
Radiologists can make manual adjustments directly in the diagnostic software if needed (adapt or delete). Volumes and coordinates are then recalculated automatically.
Alexander Cornelius, MD, Head of Radiology, Kantonsspital Aarau, Switzerland
„Basically, the structured reporting of a prostate MR is strongly recommended and this is what the mint Lesion™ system does very well. You do not have any functionality in terms of segmentation of the prostate and also the detection of tumour suspicious lesions and the additional use of the mint Lesion system with the FUSE-AI algorithm leads to a considerable increase in efficiency and objectivity, so I generally recommend structured reporting and, if possible, also using these systems to bring a little more objectivity into the interpretation of a prostate MR.“
Felice Burn, MD, Radiologist, Kantonsspital Aarau, Switzerland
„The development of innovative healthcare solutions needs strategic cooperation with competent and motivated partners, who have the capability to face the challenges and the concepts to establish a well digitalized radiology. FUSE-AI understands how to enrich with quality the healthcare market in radiology.“
Mathias Seitel, Head of Product Management, Mint Medical GmbH, Germany
„The shift towards value-based care and evidence-based medicine poses a great challenge for radiology in particular. The deliberate use of new technologies such as Artificial Intelligence is key to making this transition successful. We designed mint Lesion™ just for this purpose: a future-proof radiology workstation that combines contemporary imaging with intelligent reporting tools and thus helps radiologists assume an empowered role in the healthcare system of tomorrow. The collaboration with FUSE-AI and the Cantonal Hospital Aarau complements this strategy. Integrating Prostate.Carcinoma.ai as a plug-in into mint Lesion™ is a logical measure to reach our goal.”
Steffen Rupp, Senior Sales Director LatAm & Europe SW, Mint Medical GmbH, Germany
"Through our partnership with FUSE-AI and the combination of mint Lesion™ with Prostate.Carcinoma.ai, we complement the benefits of structured reporting with those of automatic image recognition. The high standardization, reproducibility, and quality of radiological findings now also coincide with significant efficiency increases in the reporting process," explains Steffen Rupp, Senior Sales Director at Mint Medical. "We are delighted to have found in FUSE-AI an innovative partner to support our users together on the path to data-driven and value-oriented radiology and medicine."